(Q40973791)

25 September 2017

title

Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine (English)

1 reference

25 September 2017

1 reference

1 reference

Herlocher ML

1

1 reference

25 September 2017

Ewasyshyn M

2

1 reference

25 September 2017

Sambhara S

3

1 reference

25 September 2017

Gharaee-Kermani M

4

1 reference

25 September 2017

Cho D

5

1 reference

25 September 2017

Lai J

6

1 reference

25 September 2017

Klein M

7

1 reference

25 September 2017

Maassab HF

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

25 September 2017

1 reference

25 September 2017

volume

17

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

172-181

1 reference

Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Respiratory syncytial virus--from chimps with colds to conundrums and cures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Respiratory syncytial virus and influenza A infections in the hospitalized elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

New scientific opportunities and old obstacles in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Pathogenesis of respiratory syncytial virus vaccine-augmented pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Temperature-sensitive Mutants of Respiratory Syncytial Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Genetic alteration in a temperature-sensitive mutant of respiratory syncytial virus after replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Attenuated Respiratory Syncytial Virus Vaccines in Asthmatic Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Experimental respiratory syncytial virus pneumonia in cebus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Adaptation and Growth Characteristics of Influenza Virus at 25° C

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Development and characterization of cold-adapted viruses for use as live virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Attenuated temperature-sensitive respiratory syncytial virus mutants generated by cold adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

The Development of Balb/c Cells Persistently Infected with Respiratory Syncytial Virus: Presence of Ribonucleoprotein on the Cell Surface

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Antiviral cytotoxic T lymphocyte induction and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

Rubella and mumps vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900155-8

7 January 2021

10.1016/S0264-410X(98)00155-8

Identifiers

DOI

1 reference

25 September 2017

1 reference